Physician profile
Robert L Krone
NPI 1841253853
$1,019.44
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $63.95 · 2021: $28.94 · 2022: $214 · 2023: $156 · 2024: $224 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $147.97 | 2023-2025 | Eylea Hd, Eylea |
| Johnson & Johnson Vision Care, INC. | $133.03 | 2022 | |
| Dompe US, INC. | $130.74 | 2019 | |
| Genentech USA, INC. | $103.64 | 2024 | Vabysmo |
| Alcon Vision LLC | $84.71 | 2021-2024 | Total30 |
| Bausch & Lomb Americas INC. | $82.22 | 2023-2025 | Xiidra, Xipere, Miebo |
| Apellis Pharmaceuticals, INC. | $45.54 | 2024-2025 | Syfovre |
| Spark Therapeutics, INC. | $43.04 | 2019-2021 | |
| Coherus Oncology, INC. | $41.38 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.97 | 2019-2020 | |
| Abbvie INC. | $35.07 | 2022-2023 | |
| Coopervision INC. | $26.37 | 2022 | |
| Aerie Pharmaceuticals, INC. | $22.30 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $20.61 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $20.41 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.17 | 2022 | |
| Shire North American Group INC | $13.54 | 2019 | |
| Eyevance Pharmaceuticals LLC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Krone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.